Xstelos Holdings (XTLS) Return on Equity ROE from the third quarter 2013 to third quarter 2012 and annually, average high and low, overall ranking from Sep 30 2013 to Sep 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Xstelos Holdings, Inc.  (XTLS)

Xstelos Holdings's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Xstelos Holdings in the third quarter 2013?
Xstelos Holdings, Inc. achieved a return on average equity (ROE) of 22.1 % in its third quarter 2013, which is below Xstelos Holdings's average return on equity, which stands at 41.46%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Biotechnology & Pharmaceuticals industry 4 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2013 from 0 to 356.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Equity Change -8.65 % 31.03 % 63.26 % - -
Y / Y Net Income Change -77.75 % -97.18 % - - -
Net Income (TTM) in Millions 14 16 34 36 23
Return On Equity (TTM) 22.1 % 23.98 % 54.83 % 64.91 % 57.38 %
XTLS's Total Ranking # 356 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 65 64 64 64 71
Seq. Equity Change 0.72 % 0.85 % -0.23 % -9.86 % 44.48 %
Seq. Net Income Change -14.42 % - - 558.86 % -89.16 %

Back to XTLS Management Effectiveness >> XTLS's 5 Years Annual ROE >> Compare XTLS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 5
Sector # 24
Overall # 356

Return On Equity Statistics
High Average Low
64.91 %
41.46 %
22.1 %
(Dec 31 2012)   (Sep 30 2013)





XTLS Annual Return On Equity (Dec 31 2012)
2012



Total Equity in Millions 64 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 36 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 56.61 % - - - -

Back to XTLS Management Effectiveness >> XTLS's 5 Years Annual ROE >> Compare XTLS ROE to its Competitors




Annual Roe Comment
In 2012 ROE improved to 56.61 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
XTLS's' Return on Equity at Yahoo Finance
XTLS's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for XTLS's Competitors
Subscribers only: Roe for Xstelos Holdings's Suppliers
Subscribers only: Return On Equity for XTLS's Customers




Companies with similar Return On Equity at Sep 30 2013, within Healthcare Sector ROE
Acorda Therapeutics Inc   35.61 %
Pfizer Inc  32.18 %
Waters Corporation  31.85 %
Eli Lilly And Company  30.94 %
Baxter International Inc   30.14 %
Ligand Pharmaceuticals Incorporated  30.08 %
Gilead Sciences Inc   28.53 %
Psychemedics Corporation  27.72 %
Varian Medical Systems Inc   27.09 %
Edwards Lifesciences Corporation  26.74 %
Celgene Corp  26.58 %
China Biologic Products Holdings Inc   26.47 %
Myriad Genetics Inc   25.12 %
Nrc Health  24.93 %
3m Company  24.87 %
United Therapeutics Corporation  24.73 %
Biospecifics Technologies Corp  24.50 %
Biogen Inc   22.38 %
Xstelos Holdings, Inc.  22.10 %
Healthcare Services Group Inc   21.74 %
Labcorp Holdings Inc   21.17 %
Nutrastar International Inc.  21.17 %
Addus Homecare Corp  20.70 %
Medtronic Plc  20.67 %
Akorn Inc  20.20 %
Becton Dickinson And Company  19.75 %
Quest Diagnostics Inc  19.67 %
Bristol myers Squibb Company  19.55 %
Bohai Pharmaceuticals Group, Inc.  19.54 %
Mylan N v   19.50 %

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.